Sanofi India Limited (SANOFI)
Healthcare | Drug Manufacturers - General
₹6207.0
0.38%
Margin Metrics
| Gross Margin | 51.4% |
| Operating Margin | 22.6% |
| Net Margin | 20.5% |
Return Metrics
| Return on Equity (ROE) | 0.0% |
| Return on Assets (ROA) | 25.6% |
| Return on Invested Capital (ROIC) | 1764.6% |
Profitability Analysis Score: 75/100
Profitability Score: 75/100
Key Performance Indicators:
- Excellent cost management with gross margin above 40%
- Good operational efficiency with margin above 15%
- Excellent profitability with net margin above 20%
- Excellent capital efficiency with ROIC above 20%
Recommendation
Strong Profitability - Company shows robust financial performance with good margins
Detailed Analysis
Margin Analysis: Gross margin of 51.4% indicates exceptional cost management.
Operational Efficiency: Operating margin of 22.6% shows good operational control.
Bottom Line: Net margin of 20.5% demonstrates superior overall profitability.
Risk Assessment Guide
- Score 80-100: Superior profitability with strong competitive advantages
- Score 60-79: Healthy profitability with good market position
- Score 40-59: Average profitability with improvement opportunities
- Score Below 40: Weak profitability requiring strategic intervention
Key Metrics
- Return on Equity: 0.0%
- Return on Invested Capital: 1764.6%
- Return on Assets: 25.6%
Last Updated: 16-Apr-2025 07:53 PM